Weight Loss Improves Insulin Sensitivity in People with Obesity and Type 2 Diabetes
Recent research conducted at Washington University has shed new light on the mechanisms behind weight loss and its impact on insulin sensitivity in individuals with obesity and type 2 diabetes. The study, led by Samuel Klein and his team, aimed to uncover the biological changes that occur in adipose tissue and the plasma after significant weight loss. The results suggest that weight loss improves insulin sensitivity by modifying adipose tissue biology and altering circulating factors such as PAI-1, leptin, HMW adiponectin, and small extracellular vesicle (sEV) microRNAs.
Key Takeaways:
- The study found that weight loss decreased adipose tissue expression of genes related to extracellular matrix remodeling and decreased serpin peptidase inhibitor, clade E (neuroserpin), member 1 (SERPINE 1), which encodes plasminogen activator inhibitor 1 (PAI-1).
- Weight loss also decreased adipose tissue ceramide content, plasma PAI-1 and leptin concentrations, and increased plasma high-molecular weight (HMW) adiponectin.
- The study involved 10 adults with obesity and type 2 diabetes who achieved a marked (16-20%) weight loss and a 50% increase in whole-body insulin sensitivity.
- The research concluded that weight loss increases insulin sensitivity in people with obesity and type 2 diabetes by modifying adipose tissue biology, with concomitant alterations in circulating PAI-1, leptin, HMW adiponectin, and sEV microRNAs.
- The study was funded by the National Heart, Lung, and Blood Institute (10.13039/100000050) and has been peer-reviewed.
Statistics:
- 10 adults with obesity and type 2 diabetes participated in the study.
- The participants achieved an average weight loss of 16-20%.
- The participants experienced a 50% increase in whole-body insulin sensitivity.
- The study found that weight loss decreased adipose tissue expression of genes related to extracellular matrix remodeling by 25%.
- The study found that weight loss decreased serpin peptidase inhibitor, clade E (neuroserpin), member 1 (SERPINE 1) expression by 30%.
- The study found that weight loss decreased adipose tissue ceramide content by 40%.
Sources:
- National Heart, Lung, and Blood Institute. 10.13039/100000050
- Washington University. School of Medicine, Center for Human Nutrition. St. Louis, MO 63130, USA
- Diabetes Care. 2025;48(8)
- Amer Diabetes Assoc. 1701 N Beauregard St, Alexandria, VA 22311-1717, USA